NEWS
Busy summer for Norameda’s Onko&Hospital Unit
It took us nearly a month to catch The Head of Norameda's Onko&Hospital Unit, Anton Gonak, for a short interview. While others are planning the holidays, his Unit is preparing to launch the new product and has other unexpected challenges. "We have a new medicine...
Business as usual in a face of disputes over the Lithuanian’s medicines policy
Summer brings certain anxiety to the Lithuanian pharmaceutical market. Discussions are running high over amendments to the Pharmaceutical Law and the new list of reimbursable medicines, which the government approves twice a year. The biggest concern is about possible...
‘Spring tiredness’ can be the first sign of serious illness
The 30th of May is marked as World Multiple Sclerosis Day. It brings the global MS community together to share stories, raise awareness and campaign with everyone affected by MS. As a part of the world health community, Norameda wants to share the insights of our dear...
Norameda’s sales grow steadily every year
Norameda, a leading pharmaceutical company in Baltic countries, announced a 3.2% growth in sales last year. Norameda's turnover is growing steadily every year, and in 2022 was 26,6M, 2021 - 25,8M, and 22,9M in 2020. "We are pleased with the results in all our...